230 related articles for article (PubMed ID: 20225273)
21. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
22. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
[TBL] [Abstract][Full Text] [Related]
23. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
24. T cells stimulate catabolic gene expression by the stromal cells from giant cell tumor of bone.
Cowan RW; Ghert M; Singh G
Biochem Biophys Res Commun; 2012 Mar; 419(4):719-23. PubMed ID: 22386994
[TBL] [Abstract][Full Text] [Related]
25. RANK signalling in bone lesions with osteoclast-like giant cells.
Won KY; Kalil RK; Kim YW; Park YK
Pathology; 2011 Jun; 43(4):318-21. PubMed ID: 21532526
[TBL] [Abstract][Full Text] [Related]
26. Effect of water-soluble P-chitosan and S-chitosan on human primary osteoblasts and giant cell tumor of bone stromal cells.
Tang T; Zhang G; Lau CP; Zheng LZ; Xie XH; Wang XL; Wang XH; He K; Patrick Y; Qin L; Kumta SM
Biomed Mater; 2011 Feb; 6(1):015004. PubMed ID: 21205994
[TBL] [Abstract][Full Text] [Related]
27. c/EBPbeta is a major regulatory element driving transcriptional activation of the CXCL12 promoter.
Calonge E; Alonso-Lobo JM; Escandón C; González N; Bermejo M; Santiago B; Mestre L; Pablos JL; Caruz A; Alcamí J
J Mol Biol; 2010 Feb; 396(3):463-72. PubMed ID: 19962993
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
30. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.
Nishida S; Tsubaki M; Hoshino M; Namimatsu A; Uji H; Yoshioka S; Tanimori Y; Yanae M; Iwaki M; Irimajiri K
Biochem Biophys Res Commun; 2005 Mar; 328(1):91-7. PubMed ID: 15670755
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Id2 expression by CCAAT/enhancer binding protein beta.
Karaya K; Mori S; Kimoto H; Shima Y; Tsuji Y; Kurooka H; Akira S; Yokota Y
Nucleic Acids Res; 2005; 33(6):1924-34. PubMed ID: 15809228
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
Mancino AT; Klimberg VS; Yamamoto M; Manolagas SC; Abe E
J Surg Res; 2001 Sep; 100(1):18-24. PubMed ID: 11516200
[TBL] [Abstract][Full Text] [Related]
33. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta.
Rotinen M; Celay J; Alonso MM; Arrazola A; Encio I; Villar J
J Endocrinol; 2009 Jan; 200(1):85-92. PubMed ID: 18852215
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of the Xenopus CCAAT-enhancer binding protein beta gene promoter.
Foka P; Kousteni S; Ramji DP
Biochem Biophys Res Commun; 2001 Jul; 285(2):430-6. PubMed ID: 11444861
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional cooperation between NF-kappaB p50 and CCAAT/enhancer binding protein beta regulates Nur77 transcription in Leydig cells.
El-Asmar B; Giner XC; Tremblay JJ
J Mol Endocrinol; 2009 Feb; 42(2):131-8. PubMed ID: 18996961
[TBL] [Abstract][Full Text] [Related]
36. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
37. The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment.
Giuliani N; Colla S; Morandi F; Rizzoli V
Haematologica; 2004 Sep; 89(9):1118-23. PubMed ID: 15377473
[TBL] [Abstract][Full Text] [Related]
38. Malignant B-lymphoid cells with bone lesions express receptor activator of nuclear factor-kappaB ligand and vascular endothelial growth factor to enhance osteoclastogenesis.
Shibata H; Abe M; Hiura K; Wilde J; Moriyama K; Sano T; Kitazoe K; Hashimoto T; Ozaki S; Wakatsuki S; Kido S; Inoue D; Matsumoto T
Clin Cancer Res; 2005 Sep; 11(17):6109-15. PubMed ID: 16144909
[TBL] [Abstract][Full Text] [Related]
39. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
Zheng MH; Fan Y; Wysocki SJ; Lau AT; Robertson T; Beilharz M; Wood DJ; Papadimitriou JM
Am J Pathol; 1994 Nov; 145(5):1095-104. PubMed ID: 7977641
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Wong KC; Kumta SM
Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
